Abstract

BackgroundYounger women tend to have dense breasts and early detection of breast cancer in this population remains challenging. Although MRI is more sensitive than mammography, MRI is associated with a greater false positive rate. The purpose of this study is to evaluate the relationship of MR imaging and clinical characteristics in young women with breast cancer. MethodsThe Breast Cancer Database at our medical center was queried for all women who had a mammogram and MRI from 2010–2014. Variables included demographics, risk factors, tumor characteristics, mammographic breast density (MBD), background parenchymal enhancement (BPE), and assessment of fibroglandular tissue (FGT) with contiguous MR images. Statistical analyses included Pearson's Chi Square Tests. ResultsOf 1829 women, 111 (6%) were <40 years at the time of breast cancer diagnosis. When compared to women ≥40 years, younger women more often presented with palpable masses (p<0.0001), a higher proportion of BRCA1 mutations (p=0.02), stage II–III tumors (p<0.0001), invasive ductal carcinomas (p=0.006), HER2-positive tumors (p=0.005) and higher Ki-67 scores (p=0.02). Younger women had increased MBD (p<0.0001) and increased FGT (p<0.0001) when compared to older women, however, BPE was not significantly different (p=0.70). ConclusionsYounger women had more palpable lesions and increased MBD and FGT. However, BPE was not significantly different between age groups. This suggests that BPE may not contribute to the increase in false positives associated with MRI in premenopausal women. These results underscore the importance of the clinical breast exam and breast self-awareness in young women who do not undergo routine screening. MicroabstractYounger women with breast cancer often present with palpable lesions and more advanced breast disease. Younger women tend to have increased breast density, but there is a dearth of literature on MRI characteristics in this population. Since younger women have increased breast density and are not routinely screened, improved monitoring with clinical breast exams and breast self-awareness may be important.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.